109 related articles for article (PubMed ID: 6579021)
1. Two-step enrichment of HLA-DR antigens from spent medium of human malignant melanoma culture by flotation and density separation procedures.
Khosravi MJ; Liao SK
Immunol Commun; 1983; 12(4):387-96. PubMed ID: 6579021
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.
Guerry D; Alexander MA; Herlyn MF; Zehngebot LM; Mitchell KF; Zmijewski CM; Lusk EJ
J Clin Invest; 1984 Jan; 73(1):267-71. PubMed ID: 6606651
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
4. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
5. Changes in HLA-DR antigen expression on cultured human melanoma cells during theophylline treatment.
Liao SK; Kwong PC; Dent PB; Jerry LM
Tissue Antigens; 1982 Aug; 20(2):147-51. PubMed ID: 6958088
[TBL] [Abstract][Full Text] [Related]
6. Purification and immunologic evaluation of human melnoma-associated antigens.
McCabe RP; Ferrone S; Pellegrino MA; Kern DH; Holmes EC; Reisfeld RA
J Natl Cancer Inst; 1978 Apr; 60(4):773-7. PubMed ID: 75978
[TBL] [Abstract][Full Text] [Related]
7. Functional characteristics and differential expression of class II DR, DS, and SB antigens on human melanoma cell lines.
Pollack MS; Chin-Louie J; Moshief RD
Hum Immunol; 1984 Feb; 9(2):75-87. PubMed ID: 6607912
[TBL] [Abstract][Full Text] [Related]
8. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
Ulmer AJ; Scholz W; Ernst M; Flad HD
Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
[TBL] [Abstract][Full Text] [Related]
10. Isolation of serologically active HLA-A, B, C and DR antigens as monitored by a fixed cell radioimmunoassay.
Quijano CA; Kuo M; Kindt TJ
Immunol Commun; 1983; 12(6):625-36. PubMed ID: 6609119
[TBL] [Abstract][Full Text] [Related]
11. Selective extraction by 1-butanol of surface glycoprotein antigens from human melanoma cells.
Liao SK; Smith JW; Kwong PC
Cancer Immunol Immunother; 1984; 17(2):95-9. PubMed ID: 6205747
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of HLA-DR antigens by the human melanoma cell line CaCL 73-36 upon induction of a less differentiated phenotype with bromodeoxyuridine.
Kawakubo Y; Liao SK
Anticancer Res; 1986; 6(5):1197-204. PubMed ID: 3800326
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells.
Taramelli D; Fossati G; Balsari A; Marolda R; Parmiani G
Int J Cancer; 1984 Dec; 34(6):797-806. PubMed ID: 6334655
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic heterogeneity of HLA products on human melanoma cells.
Parmiani G; Taramelli D; Anichini A; Andreola S; Cascinelli N; Fossati G
J Immunogenet; 1986; 13(2-3):235-40. PubMed ID: 3469277
[TBL] [Abstract][Full Text] [Related]
15. Approaches for the isolation of biologically functional tumor-associated antigens.
Reisfeld RA; David GS; Ferrone S; Pellegrino MA; Holmes EC
Cancer Res; 1977 Aug; 37(8 Pt 2):2860-5. PubMed ID: 301432
[TBL] [Abstract][Full Text] [Related]
16. Purification of melanoma-associated oncofetal antigen gp87 from spent medium and cell homogenate of cultured human melanoma cells.
Khosravi MJ; Liao SK
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1163-75. PubMed ID: 6541137
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia.
Herlyn M; Lange B; Bennicelli J; Blaszczyk M; Guerry D; Koprowski H
Leuk Res; 1984; 8(3):323-34. PubMed ID: 6431198
[TBL] [Abstract][Full Text] [Related]
19. Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. I. Purification and development of a radioimmunoassay.
Gupta RK; Morton DL
J Natl Cancer Inst; 1984 Jan; 72(1):67-74. PubMed ID: 6582304
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
